Literature DB >> 28416463

Glucocorticoids activate a synapse weakening pathway culminating in tau phosphorylation in the hippocampus.

Jee Hyun Yi1, Christopher Brown2, Garry Whitehead1, Thomas Piers3, Young Seok Lee4, Celia Martinez Perez1, Philip Regan5, Daniel J Whitcomb5, Kwangwook Cho6.   

Abstract

Evidence suggests that the stress hormones glucocorticoids (GCs) can cause cognitive deficits and neurodegeneration. Previous studies have found GCs facilitate physiological synapse weakening, termed long-term depression (LTD), though the precise mechanisms underlying this are poorly understood. Here we show that GCs activate glycogen synthase kinase-3 (GSK-3), a kinase crucial to synapse weakening signals. Critically, this ultimately leads to phosphorylation of the microtubule associated protein tau, specifically at the serine 396 residue, and this is a causal factor in the GC-mediated impairment of synaptic function. These findings reveal the link between GCs and synapse weakening signals, and the potential for stress-induced priming of neurodegeneration. This could have important implications for our understanding of how stress can lead to neurodegenerative disease.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  GSK-3; Glucocorticoids; Long-term potentiation; Tau

Mesh:

Substances:

Year:  2017        PMID: 28416463     DOI: 10.1016/j.phrs.2017.04.015

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  13 in total

Review 1.  Brain Under Stress and Alzheimer's Disease.

Authors:  Boris Mravec; Lubica Horvathova; Alexandra Padova
Journal:  Cell Mol Neurobiol       Date:  2017-07-11       Impact factor: 5.046

Review 2.  Brain structure alterations in depression: Psychoradiological evidence.

Authors:  Fei-Fei Zhang; Wei Peng; John A Sweeney; Zhi-Yun Jia; Qi-Yong Gong
Journal:  CNS Neurosci Ther       Date:  2018-03-05       Impact factor: 5.243

Review 3.  Central Role of Glucocorticoid Receptors in Alzheimer's Disease and Depression.

Authors:  Geoffrey Canet; Nathalie Chevallier; Charleine Zussy; Catherine Desrumaux; Laurent Givalois
Journal:  Front Neurosci       Date:  2018-10-16       Impact factor: 4.677

Review 4.  The new genetic landscape of Alzheimer's disease: from amyloid cascade to genetically driven synaptic failure hypothesis?

Authors:  Pierre Dourlen; Devrim Kilinc; Nicolas Malmanche; Julien Chapuis; Jean-Charles Lambert
Journal:  Acta Neuropathol       Date:  2019-04-13       Impact factor: 17.088

5.  Application value of selected serum indicators in the differential diagnosis of geriatric depression and transient depressive state.

Authors:  Yuhao Xu; Shun Yao; Hong Wei; Xiaolan Zhu; Ming Yu; Yuefeng Li
Journal:  Neuropsychiatr Dis Treat       Date:  2018-02-08       Impact factor: 2.570

6.  Postsynaptic p47phox regulates long-term depression in the hippocampus.

Authors:  Jee Hyun Yi; Dong Hyun Kim; Thomas M Piers; Seung Chan Kim; Daniel J Whitcomb; Philip Regan; Kwangwook Cho
Journal:  Cell Discov       Date:  2018-08-28       Impact factor: 10.849

Review 7.  Tauopathy and neurodegeneration: A role for stress.

Authors:  Jorge A Sierra-Fonseca; Kristin L Gosselink
Journal:  Neurobiol Stress       Date:  2018-09-01

8.  Rubrofusarin Attenuates Chronic Restraint Stress-Induced Depressive Symptoms.

Authors:  Jee Hyun Yi; Jieun Jeon; Huiyoung Kwon; Eunbi Cho; Jeanho Yun; Young Choon Lee; Jong Hoon Ryu; Se Jin Park; Jong Hyun Cho; Dong Hyun Kim
Journal:  Int J Mol Sci       Date:  2020-05-13       Impact factor: 5.923

9.  Planar Airy beam light-sheet for two-photon microscopy.

Authors:  Neveen A Hosny; James A Seyforth; Gunnar Spickermann; Thomas J Mitchell; Pedro Almada; Robert Chesters; Scott J Mitchell; George Chennell; Anthony C Vernon; Kwangwook Cho; Deepak P Srivastava; Robert Forster; Tom Vettenburg
Journal:  Biomed Opt Express       Date:  2020-06-22       Impact factor: 3.732

Review 10.  GSK-3 and Tau: A Key Duet in Alzheimer's Disease.

Authors:  Carmen Laura Sayas; Jesús Ávila
Journal:  Cells       Date:  2021-03-24       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.